Wave Life Sciences Ltd. - Common Stock, $0.00001 par value per share (WVE)

128 filings reported holding WVE - Wave Life Sciences Ltd. - Common Stock, $0.00001 par value per share as of Q2 2021.
Wave Life Sciences Ltd. - Common Stock, $0.00001 par value per share (WVE) has 82 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 37,041,603 shares of 189,947,836 outstanding shares and own 19.5% of the company stock.
Largest 10 shareholders include RA CAPITAL MANAGEMENT, L.P. (7,775,207 shares), DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) (4,829,069 shares), PRIMECAP MANAGEMENT CO/CA/ (4,587,566 shares), MAVERICK CAPITAL LTD (3,088,131 shares), BlackRock Inc. (2,839,335 shares), Bellevue Group AG (2,602,858 shares), Nantahala Capital Management, LLC (1,794,232 shares), D. E. Shaw & Co., Inc. (1,255,560 shares), MILLENNIUM MANAGEMENT LLC (1,137,530 shares), and JPMORGAN CHASE & CO (913,028 shares).
This table shows the top 82 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.